| X24-06-ZQ016 |
EGFR-HER2 inhibitor Alflutinib, Purity ≥98%
|
|
| X24-06-ZQ017 |
EGFR-HER2 inhibitor Almonertinib, Purity ≥98%
|
|
| X24-06-ZQ018 |
EGFR-HER2 inhibitor BDTX-189, Purity ≥98%
|
|
| X24-06-ZQ019 |
EGFR-HER2 inhibitor BGB-102, Purity ≥98%
|
|
| X24-06-ZQ020 |
EGFR-HER2 inhibitor BI-4020, Purity ≥98%
|
|
| X24-06-ZQ025 |
EGFR-HER2 inhibitor EGFR-IN-5, Purity ≥98%
|
|
| X24-06-ZQ027 |
EGFR-HER2 inhibitor Mobocertinib, Purity ≥98%
|
|
| X24-06-ZQ028 |
EGFR-HER2 inhibitor Mobocertinib succinate, Purity ≥98%
|
|
| X24-06-ZQ029 |
EGFR-HER2 inhibitor Mutated EGFR-IN-1, Purity ≥98%
|
|
| X24-06-ZQ030 |
EGFR-HER2 inhibitor Naquotinib mesylate, Purity ≥98%
|
|
| X24-06-ZQ032 |
EGFR-HER2 inhibitor NRC-2694, Purity ≥98%
|
|
| X24-06-ZQ033 |
EGFR-HER2 inhibitor Osimertinib dimesylate, Purity ≥98%
|
|
| X24-06-ZQ034 |
EGFR-HER2 inhibitor PD-089828, Purity ≥98%
|
|
| X24-06-ZQ035 |
EGFR-HER2 inhibitor PF-06459988, Purity ≥98%
|
|
| X24-06-ZQ036 |
EGFR-HER2 inhibitor Pyrotinib, Purity ≥98%
|
|
| X24-06-ZQ037 |
EGFR-HER2 inhibitor RTC-5, Purity ≥98%
|
|
| X24-06-ZQ038 |
EGFR-HER2 inhibitor SU5204, Purity ≥98%
|
|
| X24-06-ZQ039 |
EGFR-HER2 inhibitor Theliatinib, Purity ≥98%
|
|
| X24-06-ZQ040 |
EGFR-HER2 inhibitor Zipalertinib, Purity ≥98%
|
|
| X24-08-YM001 |
EGFR-HER2 inhibitor, Lifirafenib, Purity ≥98%
|
|
